KIYATEC has partnered with Greenville Health System’s Institute for Translational Oncology Research (ITOR). Greenville Health System represents the 13th largest public health system in the United States. As a phase one clinical site dedicated to cutting-edge cancer care, ITOR’s Clinical Research Unit manages an average of 20 active clinical trials, including a number of first-in-man studies. KIYATEC offices and laboratory operations are co-located within the ITOR Innovation Zone providing excellent clinical connectivity and access to primary tissue samples via IRB-approved protocols. Direct interaction with oncologists provides valuable feedback and insight necessary to effectively translate the company’s core technology into clinically-relevant diagnostics impacting the future of patient-specific cancer care.
KIYATEC is an active commercial partner of several esteemed university programs and centers across the United States. Each of these academic research partners have received numerous NIH and NSF funded awards and are recognized leaders in their respective fields.